Persistent prurigo nodularis responsive to initiation of combination therapy with raltegravir

Arch Dermatol. 2010 Jun;146(6):682-3. doi: 10.1001/archdermatol.2010.128.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Administration, Oral
  • Anti-HIV Agents / therapeutic use*
  • Biopsy
  • Dose-Response Relationship, Drug
  • Drug Therapy, Combination
  • Follow-Up Studies
  • HIV Seropositivity / complications*
  • HIV Seropositivity / drug therapy
  • Humans
  • Male
  • Middle Aged
  • Prurigo / complications
  • Prurigo / diagnosis
  • Prurigo / drug therapy*
  • Pyrrolidinones / administration & dosage*
  • Raltegravir Potassium
  • Skin / pathology

Substances

  • Anti-HIV Agents
  • Pyrrolidinones
  • Raltegravir Potassium